Who owns CTK Biotech?

At the helm of this dynamic organization is the Group CEO, strategically located in Hilleroed, Denmark. From this base, they steer the direction of the Group, ensuring seamless integration and growth across all subsidiaries.

CTK and BGB are two integral components of the SSI Diagnostica A/S Group, operating as wholly-owned subsidiaries under its umbrella. This consolidation underscores the Group's commitment to expanding its diagnostic solutions portfolio.

By maintaining close business cooperation throughout the year, CTK, BGB, and the rest of the SSI Diagnostica A/S Group remain agile and responsive to the needs of the market. This collaborative approach fosters a culture of continuous improvement, allowing the Group to stay ahead of the curve in the diagnostic technology sector.

Recognizing the importance of innovation and advancement, the Group fosters continuous collaboration between its R&D and technical personnel. This collaborative effort spans throughout the year, driving the development of cutting-edge diagnostic technologies.

The R&D team, fueled by a passion for innovation, remains at the forefront of the industry. They are constantly exploring new avenues to enhance diagnostic accuracy and efficiency, keeping pace with the rapidly evolving global diagnostic landscape.